TOBRADEX OPHTHALMIC SUSPENSION 5ML

$25.40
No tax

TOBRADEX OPHTHALMIC SUSPENSION 5ML

Quantity

 

Security policy (edit with Customer reassurance module)

 

Delivery policy (edit with Customer reassurance module)

 

Return policy (edit with Customer reassurance module)

Active ingredient and dosage form

Tobradex eye drops:
1 ml contains tobramycin 3 mg, Dexamethasone 1 mg;
Excipients: benzalkonium chloride, disodium edetate, sodium chloride, anhydrous sodium sulfate, tyloxapol, hydroxyethyl cellulose, sulfuric acid and / or sodium hydroxide (before pH adjustment), purified water;
in vials of 5 ml (with dispenser "Drop Tainer ™").

Mechanism of action

Tobradex has a local anti-bacterial, anti-inflammatory local effect.

Indications and usage

prevention of postoperative infections;
blepharitis;
conjunctivitis;
keratitis (without damage to the epithelium).

Contraindications

individual hypersensitivity to components of Tobradex;
viral diseases of the cornea and conjunctiva (including keratitis caused byHerpes simplex, chickenpox);
mycobacterial infection of the eye;
fungal diseases of the eye;
condition after removal of the cornea foreign body.

Pregnancy and Breastfeeding

Sufficient experience on the use of Tobradex during pregnancy, breastfeeding is not. Perhaps the use for the treatment of pregnant women as prescribed by the attending physician, if the expected therapeutic effect exceeds the risk of possible side effects.It is necessary to interrupt the use of the drug for the period of breastfeeding.

Dosage and administration

In the conjunctival sac.
Eye drops Tobradex: 1–2 drops every 4–6 hours. In the first 24–48 hours, the dose may be increased to 1–2 drops every 2 hours.

Adverse reactions

Hypersensitivity and allergic reactions (itching, eyelid swelling, conjunctival hyperemia).
Side effects caused by the steroid component: increased intraocular pressure; rear subcapsular cataract, slowing the healing process of wounds.
Secondary infection. The development of a secondary infection is observed after the use of combined drugs containing GCS in combination with antibiotics. Fungal infections of the cornea tend to occur particularly often with long-term use of steroids. The appearance of non-healing ulcers on the cornea after long-term treatment with steroid preparations may indicate the development of fungal invasion. Secondary bacterial infection may occur as a result of suppression of the protective reaction of the patient.

The bottle must be closed after each use.
Do not touch the eye with a pipette tip.
The dropper bottle DropTayner with eye drops should be shaken before use, stored upright.

Storage conditions

In the dark place at a temperature of no higher than 25 ° C.

24 Items